2023 annual financial data
Cadrenal Therapeutics 2023 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -7,632,843 USD and net income was -8,357,086 USD.
Operating cash flow was -3,530,323 USD.
Get free Cadrenal Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,632,843 USD
- Net income
- -8,357,086 USD
- Operating cash flow
- -3,530,323 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Cadrenal Therapeutics financial years